Highly Pathogenic Avian Influenza, more commonly known as H5N1 or bird flu, claimed its first human victim in the United States earlier this month. In the past year, it's resulted in the deaths of ...
A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...